Answers are grounded in this paper and cite their sources.
Novel human-like collagen (HLC)/chitosan hybrid scaffolds were fabricated at blend ratios of 0%, 0.02%, 0.2% by crosslinking and freeze-drying process. The properties of the scaffolds were investigated, including morphology, mechanical strength, degradability, and cell biocompatibility. When the blend ratio was 0.02%, the morphology of the scaffolds was highly homogeneous with interconnected porous structure 46 ± 9 μm in size (SEM). The X-ray photoelectron spectroscopy analysis indicated intermolecular crosslinks between HLC and chitosan. The strain and stress of the scaffolds were 37.9 ± 3.3% and 309.7 ± 19.7 KPa, respectively. Human venous fibroblasts were expanded and seeded into the scaffolds in the density of 1 × 10 5 cells/cm 3 under static conditions. The cell morphology and proliferation were investigated using SEM, H&E, and MTT assay, which showed that the optimal content of the chitosan was signifcantly enhanced the cells adhesion, proliferation, and viability, compared to pure HLC, pure chitosan, and 0.2% chitosan/HLC scaffolds. These hybrid scaffolds appear to have favorable characteristics for vascular tissue engineering application.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: